Delivery Order SPE2DB22D2206-SPE2DB24FFQ32
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $1,076.56 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,299,676 units of 40mg Atorvastatin tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,528.19, is a delivery order for 4,566,817,242 units of Atorvastatin 40 mg tablets. The award has an ultimate completion date of January 2, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.51 firm-fixed-price delivery order is for the supply of 4,559,305,598 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,491.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Atorvastatin 40 mg, a commonly prescribed statin medication used to manage cholesterol and cardiovascular health. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and was awarded on September 17, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,905.06 firm fixed price delivery order is for 4,562,470,723 units of the drug Atorvastatin 40 mg tablets. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The order is for 4,564,097,707 units of Atorvastatin 10 mg tablets, a generic pharmaceutical product, with a ceiling value of $3,735.53. The delivery order has an ultimate completion date of March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up...
- This federal contract award, valued at $1,627.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- The Defense Logistics Agency awarded a delivery order valued at $3,278.97 to AmerisourceBergen Drug Corp for the supply of Atorvastatin 80 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...